Bradford Dahms

Bradford Dahms

Chief Financial OfficeratJade Biosciences· In the 2025 proxy

Pay in FY2025Jade Biosciences stock +59.2% the same year

Bradford Dahms was paid $4.1M in FY2025 (Dec). Jade Biosciences stock rose 59.2% that year.

Pay$100 in the stock at the end of FY24 → $159
Pay is from the Summary Compensation Table of each Jade Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Jade BiosciencesPublic company · 1 yr
    • Chief Financial Officer2025 – Present · 1 yrStock in role +53%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?